These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 27685524)

  • 1. Enterosorption combined with granulocyte colony stimulating factor decreases melphalan gonadal toxicity.
    Shevchuk OO; Bodnar YY; Bardakhivskaya KI; Datsko TV; Volska AS; Posokhova КА; Chekhun VF; Nikolaev VG
    Exp Oncol; 2016 Sep; 38(3):172-5. PubMed ID: 27685524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of enterosorption on some haematological and biochemical indices of the normal rats after single injection of melphalan.
    Shevchuk OO; Posokhova KA; Sidorenko AS; Bardakhivskaya KI; Maslenny VM; Yushko LA; Chekhun VF; Nikolaev VG
    Exp Oncol; 2014 Jun; 36(2):94-100. PubMed ID: 24980763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of myelosuppression by combined treatment with enterosorbent and granulocyte colony-stimulating factor.
    Shevchuk OO; Posokhova КА; Todor IN; Lukianova NY; Nikolaev VG; Chekhun VF
    Exp Oncol; 2015 Jun; 37(2):135-8. PubMed ID: 26112942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Primary and Secondary Beads of Carbon Enterosorbent on Haematological Parameters and Oxidative Stress Development Caused by Melphalan in Rats.
    Shevchuk O; Snezhkova E; Sarnatskaya V; Mikhailenko V; Glavin A; Makovetska L; Bardakhivska K; Birchenko I; Kozynchenko O; Nikolaev V
    Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31480729
    [No Abstract]   [Full Text] [Related]  

  • 5. Granulocyte colony-stimulating factor (G-CSF) promotes spermatogenic regeneration from surviving spermatogonia after high-dose alkylating chemotherapy.
    Kotzur T; Benavides-Garcia R; Mecklenburg J; Sanchez JR; Reilly M; Hermann BP
    Reprod Biol Endocrinol; 2017 Jan; 15(1):7. PubMed ID: 28077131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
    Bregni M; Siena S; Di Nicola M; Dodero A; Peccatori F; Ravagnani F; Danesini G; Laffranchi A; Bonadonna G; Gianni AM
    J Clin Oncol; 1996 Feb; 14(2):628-35. PubMed ID: 8636780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
    Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
    Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human granulocyte colony-stimulating factor infusion and/or autologous peripheral blood stem cell transplantation as a rescue for sequential high-dose combination chemotherapy: a preliminary report.
    Chau WK; Lin CK; Chow MP; Wang SY; Liu JM; Ho CH; Chiu CF; Hsu HC; Tan TD; Chan WK
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Nov; 54(5):312-20. PubMed ID: 7530591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF.
    Ballestrero A; Ferrando F; Garuti A; Basta P; Gonella R; Stura P; Mela GS; Sessarego M; Gobbi M; Patrone F
    J Clin Oncol; 1999 Apr; 17(4):1296. PubMed ID: 10561192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly activated carbon enterosorbent mediates the suppression of paraneoplastic syndrome associated with Lewis lung carcinoma in mice.
    Sarnatskaya VV; Sakhno L; Paziuk LM; Yushko LA; Rodionova NK; Maslenniy VN; Sidorenko AS; Nikolaev V
    Exp Oncol; 2018 Mar; 40(1):33-41. PubMed ID: 29600975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy.
    Morstyn G; Campbell L; Lieschke G; Layton JE; Maher D; O'Connor M; Green M; Sheridan W; Vincent M; Alton K
    J Clin Oncol; 1989 Oct; 7(10):1554-62. PubMed ID: 2789274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.
    Koç ON; Gerson SL; Cooper BW; Laughlin M; Meyerson H; Kutteh L; Fox RM; Szekely EM; Tainer N; Lazarus HM
    J Clin Oncol; 2000 May; 18(9):1824-30. PubMed ID: 10784622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enterosorption as a method to decrease the systemic toxicity of cisplatin.
    Sakhno LA; Yurchenko OV; Maslenniy VN; Bardakhivskaya KI; Nikolaeva VV; Ivanyuk AA; Shevchuk OO; Korotich VG; Nikolaev VG
    Exp Oncol; 2013 Mar; 35(1):45-52. PubMed ID: 23528316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
    Hohaus S; Martin H; Wassmann B; Egerer G; Haus U; Färber L; Burger KJ; Goldschmidt H; Hoelzer D; Haas R
    Bone Marrow Transplant; 1998 Oct; 22(7):625-30. PubMed ID: 9818688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma.
    Moreau P; Fiere D; Bezwoda WR; Facon T; Attal M; Laporte JP; Colombat P; Haak HL; Monconduit M; Lockhorst H; Girault D; Harousseau JL
    J Clin Oncol; 1997 Feb; 15(2):660-6. PubMed ID: 9053491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant and sequential administration of recombinant human granulocyte colony-stimulating factor and recombinant human interleukin-3 to accelerate hematopoietic recovery after autologous bone marrow transplantation for malignant lymphoma.
    Lemoli RM; Rosti G; Visani G; Gherlinzoni F; Miggiano MC; Fortuna A; Zinzani P; Tura S
    J Clin Oncol; 1996 Nov; 14(11):3018-25. PubMed ID: 8918500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of human recombinant granulocyte colony-stimulating factor on rat busulfan-induced testis injury.
    Khanlarkhani N; Pasbakhsh P; Mortezaee K; Naji M; Amidi F; Najafi A; Sobhani A; Zendedel A
    J Mol Histol; 2016 Feb; 47(1):59-67. PubMed ID: 26714726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
    Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-arterial infusion of 5-fluorouracil plus granulocyte-macrophage colony-stimulating factor (GM-CSF) and chemoembolization with melphalan in the treatment of disseminated colorectal liver metastases.
    Müller H; Nakchbandi W; Chatzissavvidis I; Valek V
    Eur J Surg Oncol; 2001 Nov; 27(7):652-61. PubMed ID: 11669594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.